1. Provide indication, target symptoms, and affected neurotransmitters.
2. Include half-life and CYP 450 enzyme information.
3. List notable side effects and link notable side effects to the associated pathway or neurotransmitter.
4. List Initial Dosing Considerations and specific lifespan considerations (age, pregnancy, breastfeeding).